Invicro is a leading provider of quantitative biomarkers, advanced analytics, and imaging solutions that enhance the discovery and development of life-changing drugs. With expertise spanning multiple therapeutic areas, including oncology, central nervous system, and respiratory, Invicro serves top pharma and biotech companies from molecular discovery through late-phase clinical trials.
Driven by advanced technology solutions, Invicro supports all phases of drug discovery and development, offering capabilities such as preclinical imaging, early clinical imaging, clinical imaging core lab, pathology services, radiochemistry, and image analysis software. With a track record of managing thousands of research and clinical trials, Invicro is a trusted partner in the field of drug development.
Generated from the website